Medication info
Pitavrowong 2mg (Pitavastatin Calcium)

Pitavrowong 2mg (Pitavastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium›2mg / 1 tablet
Manufacturer / importer
JongKundang Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 201103424 · Approved 2011.05.24 · Insurance code 643306060

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 mg daily. Depending on the LDL cholesterol level, treatment goal, and patient response, the dose should be appropriately adjusted at intervals of 4 weeks or longer. The therapeutic effect of this drug is maintained with continued administration.

Ingredients

Manufacturer
JongKundang Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo-B protein
  • elevated triglycerides
View approved original text

This medication helps lower elevated total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It also aids in increasing HDL cholesterol levels to maintain a healthy fat balance. It is primarily used as an adjunct to dietary therapy, effective in improving blood lipids. These actions contribute to the reduction of cardiovascular disease risk. It is used to improve patients' blood lipid status.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 mg daily. Depending on the LDL cholesterol level, treatment goal, and patient response, the dose should be appropriately adjusted at intervals of 4 weeks or longer. The therapeutic effect of this drug is maintained with continued administration.

Precautions

This medication should not be used in certain patients. It is not for individuals who are allergic to any ingredient in this medication, those with severe liver dysfunction, those with bile duct obstruction, those taking cyclosporine, those with myopathy, pregnant or potentially pregnant women, nursing mothers, and children. Additionally, it should be used cautiously in individuals with kidney or liver issues, those consuming alcohol excessively, those taking fibrate drugs or niacin, those with hypothyroidism or a family history of muscle disorders, elderly individuals, and patients with severe myasthenia gravis. Symptoms such as muscle pain, weakness, and liver dysfunction may occur during treatment, and if they do, patients should consult a physician immediately. Particularly, if muscle pain is accompanied by elevated creatine phosphokinase (CPK) levels in blood tests, it may indicate serious muscle damage known as rhabdomyolysis, so caution is advised. Liver function tests should be performed regularly before and after treatment, and if liver levels increase, discontinuation of the medication may be required. This medication may interact with other drugs, so caution is especially needed when taken with cyclosporine, fibrate drugs, niacin, or erythromycin. Acute renal function deterioration can occur when used in combination with these drugs, so consultation with a physician is imperative. Elderly patients may exhibit adverse reactions more readily due to decreased physical function, so increased caution is warranted during administration. Pregnant or nursing women should not use this medication, and those planning to become pregnant should consult a physician before use. This medication has not been confirmed for safety and efficacy in children, so it is not used for them. Store this medication out of reach of children, and keep it in its original container to prevent misuse or degradation of quality. Finally, since this medication is used for the treatment of hypercholesterolemia, it is important to check blood lipid levels before administration and to combine it with dietary and exercise therapies. If there is no therapeutic effect, the medication should be discontinued.

Side effects

  • Abdominal pain
  • rash
  • fatigue
  • paralysis
  • itching
  • myalgia
  • weakness
  • increased CPK levels
  • elevated myoglobin in blood and urine
  • acute renal failure
Show 83 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • hives
  • erythema
  • angioedema
  • increased bilirubin
  • elevated cholinesterase
  • increased AST
  • increased ALT
  • increased γ-GT
  • increased ALP
  • increased LDH
  • rigidity
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • dry mouth
  • dyspepsia
  • abdominal distension
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • stomach discomfort
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • increased globulin
  • positive Coombs test
  • anemia
  • increased frequency of urination
  • increased BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • increased adrenocorticotropic hormone
  • increased cortisol
  • decreased testosterone
  • muscle cramps
  • loss of strength
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • increased uric acid level
  • elevated serum potassium and phosphorus
  • taste disturbances
  • fatigue
  • positive antinuclear antibody
  • sleep disorder
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes mellitus
  • immune-mediated necrotizing myopathy
  • severe muscle weakness
  • ocular myasthenia
  • facial edema
  • arm edema
  • hypersensitivity
  • headache
  • dizziness
  • skin tingling
  • insomnia
  • loss of appetite
  • increased blood pressure
  • chest discomfort
  • weakness
  • nausea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in an opaque container, and the temperature should be kept between 1 and 30 degrees Celsius at room temperature. Maintaining the proper storage environment helps preserve the medication's effectiveness.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.